Company / FCF Margin
UroGen Pharma Ltd. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-148.2%
FY2025
5-year range
-199.8% / -136.5%
FY2021-FY2025
Trend
+25.8%
vs FY2024
Sector context
#95 of 134
Health Care
What the data says
At -148.2%, UroGen Pharma Ltd.'s fcf margin ranks #95 of 134 in the Health Care sector. FCF Margin has fluctuated over the past 9 years, ranging from -396344.4% in FY2020 to 19.9% in FY2016.
Based on SEC 10-K filings.
-148.2% in FY2025 with a 5-year CAGR of +396196.2%.
Declined from -136.5% to -148.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +30.0pp
- 5-Year Change
- +396196.2pp
- 10-Year Change
- -
Sector benchmark
#95 of 134 in Health CareTop 71% of 134This company -148.2% Sector average -637.8%
▼
+76.8% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 25.8% year-over-year.
- Currently 489.6pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -148.2% | +25.8% |
| FY2024 | -199.8% | -46.4% |
| FY2023 | -136.5% | +23.5% |
| FY2022 | -178.3% | +0.0% |
| FY2021 | -178.3% | +100.0% |
| FY2020 | -396344.4% | -328516.6% |
| FY2019 | -120.6% | +96.4% |
| FY2018 | -3359.4% | - |
| FY2017 | - | - |
| FY2016 | 19.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026